Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

2.4%

11 terminated/withdrawn out of 452 trials

Success Rate

93.5%

+6.9% vs industry average

Late-Stage Pipeline

22%

98 trials in Phase 3/4

Results Transparency

1%

2 of 159 completed trials have results

Key Signals

73 recruiting2 with results9 terminated

Enrollment Performance

Analytics

N/A
121(35.1%)
Phase 2
92(26.7%)
Phase 4
70(20.3%)
Phase 3
28(8.1%)
Phase 1
22(6.4%)
Early Phase 1
12(3.5%)
345Total
N/A(121)
Phase 2(92)
Phase 4(70)
Phase 3(28)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (452)

Showing 20 of 452 trials
NCT07854145Not ApplicableNot Yet Recruiting

Starry-Sky Projection and Maternal Voice for Sleep After Pediatric Cardiac Surgery

Role: lead

NCT07848152Recruiting

Active Surveillance and Safety/Efficacy Evaluation of Innovative Devices for Structural Heart Disease Intervention

Role: lead

NCT07844941Not ApplicableRecruiting

Artificial Intelligence (AI)-Based Personalized Exercise Coaching for Patients With Breast Cancer

Role: lead

NCT07816900Not ApplicableCompleted

Efficacy and Safety of Da-Cheng-Qi Decoction in Severe Acute Pancreatitis

Role: lead

NCT07833228Not ApplicableNot Yet Recruiting

A Multicenter Randomized Double-Blind Trial of Chrocare CDSS for Integrated Management of Type 2 Diabetes

Role: lead

NCT07645677Not ApplicableNot Yet Recruiting

Circadian-Synchronized Breast Milk Feeding and Sleep in Preterm Infants: A Multicenter Randomized Controlled Trial

Role: lead

NCT07625449Not ApplicableNot Yet Recruiting

Early Lumbar Drainage for Intraventricular Hemorrhage

Role: collaborator

NCT07799831Recruiting

Oral Health, Saliva Bacteria, and Disease Activity in Children With JIA: A Cross-Sectional Study.

Role: lead

NCT07516262Completed

Effect of PPIs on Stool DNA Test for H. Pylori

Role: lead

NCT07797218Phase 3Recruiting

Neoadjuvant Pyrotinib-to-pertuzumab in HER2+ eBC

Role: lead

NCT07778771Not ApplicableNot Yet Recruiting

CEEEC-II: A 12-Week Physical and Cognitive Enrichment Extension Study in Older Stroke Survivors With Multimorbidity

Role: collaborator

NCT07025889Phase 1Recruiting

IBI343 Combined With Sintilimab Plus Chemotherapy in Gastric Cancer

Role: collaborator

NCT07761702Phase 3Not Yet Recruiting

Umbilical Cord Blood Consolidation for Older Adults With Intermediate- and High-Risk AML

Role: lead

NCT06528080Early Phase 1Active Not Recruiting

A Clinical Study for the Treatment of Pediatric and Adolescent Patients With Type 1 Gaucher Disease

Role: lead

NCT05715307Not ApplicableCompleted

Chinese Endocrinologists Health Education Study

Role: lead

NCT07389759Not ApplicableCompleted

Impact of CADx on Endoscopists' Histologic Characterization of Diminutive Colorectal Polyps

Role: lead

NCT07641010Phase 1Not Yet Recruiting

PD-1 Antibody and JAK1 Inhibitor for Newly Diagnosed Pediatric Hodgikin's Lympoma

Role: lead

NCT03932136Phase 3Active Not Recruiting

Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial)

Role: lead

NCT07303803Phase 2Recruiting

A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus

Role: lead

NCT06979232Not ApplicableCompleted

Enhanced White Light Endoscopy Versus Conventional White Light Endoscopy for Colorectal Adenoma Detection: A Randomized Controlled Trial

Role: lead